ピラジナミドは,Mycobacterium tuberculosisにおけるトランス翻訳を阻害する
Wanliang Shi1, Xuelian Zhang, Xin Jiang
1W. Harry Feinstone Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA.
Science (New York, N.Y.)
|August 13, 2011
まとめ
結核の重要な薬であるピラジナミドは,トランス翻訳を阻害することによって作用します. 研究者は,リボソームタンパク質S1 (RpsA) を薬の標的として特定し,それが持続的な結核感染症とどのように戦うかを説明しました.
科学分野:
- 微生物学 微生物学とは
- 分子生物学は分子生物学である.
- ドラッグ・ディスカバリー・ディスカバリー・ドラッグ・ディスカバリー・ドラッグ・ディスカバリー
背景:
- ピラジナミド (PZA) は,結核の第一線薬である.
- Mycobacterium tuberculosisにおけるその作用機構と細胞内標的は,ほとんど不明のままである.
- PZA耐性は,ピラジナミダゼ (PZase) をコードするpncA遺伝子の変異としばしば関連しています.
研究 の 目的:
- PZAの活性形態であるピラジノ酸 (POA) の難解な分子標的を特定する.
- POAがバクテリアの成長を抑制し,PZA耐性を授与するメカニズムを解明する.
主な方法:
- PZA耐性臨床単離物の遺伝子分析.
- バイオケミカルアッセイは,POAがターゲットに結合することを確認します.
- PZA耐性に対するRpsA過剰発現の影響の評価.
- トランス翻訳とカノニカル翻訳の抑制研究.
主要な成果:
- リボソームタンパク質S1 (RpsA) は,POA.の新たな標的として特定されました.
- RpsAの変異は,pncA変異を欠いたPZA耐性菌株で見つかりました.
- POAはRpsAに直接結合し,トランス翻訳の重要なプロセスを阻害する.
- 複製しない細菌にとって重要なトランス翻訳の阻害は,持続性結核に対するPZAの有効性を説明します.
結論:
- リボソームタンパク質S1 (RpsA) は,ピラジナミドの活性代謝物であるピラジノ酸の分子標的である.
- POAによるトランス翻訳の阻害は,持続的なMycobacterium tuberculosisに対するPZAの殺菌活性の主なメカニズムです.
- この発見は,PZA耐性を理解し,新しい抗結核戦略を開発するための新しい道を開きます.
関連する概念動画
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
02:42Transcription Attenuation in Prokaryotes
Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure. Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:23Types of RNA
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...